Pricing Log in Create free account
Saturday 17 October 2026 Export ZTS’s income statement to Excel — free account

Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 2.48%, free cash flow grew 17.4% and total debt rose 37.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

79.20 0.78 +0.99%
Market cap
$32.4B
P/E
13.0×
Fwd P/E
12.3×
Dividend yield
2.64%
F-score
7/9
Altman Z
5.73
Beneish M
−2.45
Dividend safety
88/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zoetis Inc. (ZTS) Book value per share

Alert me on Book value per share

Zoetis Inc.'s book value per share at the end of fiscal 2025 was 7.5×, down 28.5% from 10.5× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 7.5×. Over the past ten years it has ranged from 2.2× (fiscal 2015) to 10.8× (fiscal 2023); the current reading is higher than 55% of that period. Zoetis Inc. ranks 25th of 86 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 7.5× (28.47%)
FY2024 10.5× (2.96%)
FY2023 10.8× 15.25%
FY2022 9.4× (1.98%)
FY2021 9.6× 20.73%
FY2020 7.9× 40.10%
FY2019 5.7× 25.22%
FY2018 4.5× 24.08%
FY2017 3.6× 20.56%
FY2016 3.0× 38.50%

Quarterly newest first

Period Book value per share Change
Jun 2026 7.5× (1.58%)
Mar 2026 7.7× (0.54%)
Dec 2025 7.7× (36.81%)
Sep 2025 12.2× 9.00%
42 more quarters

Against its own ten years

Low 2.2× High 10.8×
Ten-year median 7.5×
Current reading's percentile 55

Book value per share against peers

Company Book value per share
UTHR United Therapeutics Corporation compare 150×
NBIX Neurocrine Biosciences, Inc. compare 36.6×
TAK Takeda Pharmaceutical Co. compare 15.1×
ELAN Elanco Animal Health Incorporated compare 13.2×
VTRS Viatris Inc. compare 12.3×
ZTS Zoetis Inc. 7.5×
TEVA Teva Pharmaceutical Industries Ltd. compare 6.7×
RDY Dr. Reddy's Laboratories Ltd compare 5.2×
HLN Haleon PLC Sponsored ADR compare 0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on ZTS